A Podcast on Patient and Physician Perspectives on the Management of Endometriosis and Relugolix Combination Therapy

被引：0
|
作者：
Mangum, Tara [1 ]
Agarwal, Sanjay K. [2 ]
机构：
[1] Yellow Cape, Patient Author, Newark, DE USA
[2] Univ Calif San Diego, Ctr Endometriosis Res & Treatment, La Jolla, CA 92093 USA
来源：
ADVANCES IN THERAPY | 2024年 / 41卷 / 12期
关键词：
Endometriosis; Quality of life; GnRH antagonists; Relugolix combination therapy; WOMEN; CARE; DELAY; PAIN;
D O I：
10.1007/s12325-024-02970-2
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Endometriosis is a common disease, affecting approximately 5-10% of reproductively aged women. Symptoms, such as painful periods, negatively impact an individual's quality of life; however, these symptoms are often normalized, leading to delays in diagnosis and treatment, and worsening of the disease. In this podcast, a reproductive endocrinologist (Dr Sanjay K Agarwal) and patient advocate (Tara Mangum) provide their perspectives on the diagnosis and management of endometriosis. They also discuss Relugolix combination therapy as a treatment option for patients with endometriosis.Podcast available for this article.
引用
收藏
页码：4369 / 4376
页数：8
相关论文
共 50 条
  • [21] Patient and physician perspectives on the management of inflammatory bowel disease: Role of steroids in the context of biologic therapy
    Afzali, A.
    Armuzzi, A.
    Bouhnik, Y.
    Bressler, B.
    Hart, A.
    Rubin, D.
    Sans, M.
    Siegmund, B.
    Sninsky, D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S366 - S367
  • [22] Treatment of Uterine Fibroid Symptoms With Relugolix Combination Therapy
    Learman, Lea A.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2021, 76 (06) : 334 - 336
  • [23] A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women
    Lukes, Andrea
    Migoya, Elizabeth
    Johnson, Brendan
    Lee, Tien-Yi
    Li, Yulan
    Ferreira, Juan Camilo Arjona
    CLINICAL PHARMACOKINETICS, 2023, 62 (08) : 1169 - 1182
  • [24] A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women
    Andrea Lukes
    Elizabeth Migoya
    Brendan Johnson
    Tien-Yi Lee
    Yulan Li
    Juan Camilo Arjona Ferreira
    Clinical Pharmacokinetics, 2023, 62 : 1169 - 1182
  • [25] Current perspectives on combination therapy in the management of hypertension
    Mallat, Samir G.
    Itani, Houssam S.
    Tanios, Bassem Y.
    INTEGRATED BLOOD PRESSURE CONTROL, 2013, 6 : 69 - 78
  • [26] Sickle Cell Disease and Gene Therapy - Patient and Physician Perspectives
    不详
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (13): : 1156 - 1156
  • [27] Living with Type 2 Diabetes: Podcast of a Patient–Physician Discussion
    Pamela Kushner
    Anne Dalin
    Diabetes Therapy, 2023, 14 : 621 - 627
  • [28] Patient, Caregiver, and Physician Perspectives of Acute Concussion Care and Management
    Foster, Evan
    Szczypinski, Monica
    Chandra, Tharshini
    Comper, Paul
    Bayley, Mark
    JOURNAL OF HEAD TRAUMA REHABILITATION, 2024, 39 (04) : E290 - E291
  • [29] Effects of relugolix combination therapy on endometriosis-associated pain and analgesic use in spirit studies: overall study and european populations
    Venturella, R.
    As-Sanie, S.
    Kotarski, J.
    Mehedintu, C.
    Imm, S.
    Qurratul, A.
    Becker, C.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 270 : E32 - E33
  • [30] Sustained efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT 52-week data
    As-Sanie, S.
    Giudice, L.
    Abrao, M. S.
    Wilk, K.
    Mehedintu, C.
    Becker, C.
    Ferreira, J. C. Arjona
    Wagman, R. B.
    Wang, F.
    Warsi, Q. A.
    Neil, J.
    HUMAN REPRODUCTION, 2021, 36 : 57 - 58
12345